| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL2A1 COL5A1 COL6A1 COL24A1 OTOL1 COL9A1 COL9A2 COL6A6 COL27A1 | 3.99e-17 | 46 | 34 | 9 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL5A1 COL6A1 COL24A1 OTOL1 COL9A1 COL9A2 COL6A6 COL27A1 | 2.05e-11 | 188 | 34 | 9 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL5A1 COL6A1 COL24A1 OTOL1 COL9A1 COL9A2 ERVK-9 BSN COL6A6 MRPL16 COL27A1 | 1.28e-08 | 891 | 34 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 9.82e-07 | 12 | 34 | 3 | GO:0048407 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL2A1 POMGNT1 COL5A1 COL6A1 COL24A1 OTOL1 COL9A1 COL9A2 COL27A1 | 7.25e-09 | 377 | 34 | 9 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL2A1 POMGNT1 COL5A1 COL6A1 COL24A1 OTOL1 COL9A1 COL9A2 COL27A1 | 7.42e-09 | 378 | 34 | 9 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL2A1 POMGNT1 COL5A1 COL6A1 COL24A1 OTOL1 COL9A1 COL9A2 COL27A1 | 7.59e-09 | 379 | 34 | 9 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 7.26e-06 | 76 | 34 | 4 | GO:0030199 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 6.31e-05 | 47 | 34 | 3 | GO:0060351 | |
| GeneOntologyBiologicalProcess | positive regulation of granulocyte differentiation | 1.72e-04 | 12 | 34 | 2 | GO:0030854 | |
| GeneOntologyBiologicalProcess | regulation of ribonucleoprotein complex localization | 2.03e-04 | 13 | 34 | 2 | GO:2000197 | |
| GeneOntologyBiologicalProcess | connective tissue development | 2.31e-04 | 343 | 34 | 5 | GO:0061448 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex localization | 2.37e-04 | 14 | 34 | 2 | GO:0071166 | |
| GeneOntologyBiologicalProcess | endochondral bone morphogenesis | 2.97e-04 | 79 | 34 | 3 | GO:0060350 | |
| GeneOntologyCellularComponent | collagen trimer | COL2A1 COL5A1 COL6A1 COL24A1 OTOL1 COL9A1 COL9A2 C1QTNF3 COL6A6 COL27A1 | 1.25e-16 | 88 | 34 | 10 | GO:0005581 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL2A1 COL5A1 COL6A1 COL24A1 OTOL1 COL9A1 COL9A2 COL6A6 COL27A1 | 1.21e-07 | 530 | 34 | 9 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | COL2A1 COL5A1 COL6A1 COL24A1 OTOL1 COL9A1 COL9A2 COL6A6 COL27A1 | 7.26e-07 | 656 | 34 | 9 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL2A1 COL5A1 COL6A1 COL24A1 OTOL1 COL9A1 COL9A2 COL6A6 COL27A1 | 7.44e-07 | 658 | 34 | 9 | GO:0030312 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 8.56e-07 | 12 | 34 | 3 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 8.56e-07 | 12 | 34 | 3 | GO:0098643 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 8.90e-07 | 332 | 34 | 7 | GO:0005788 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 5.12e-06 | 21 | 34 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen type IX trimer | 1.54e-05 | 4 | 34 | 2 | GO:0005594 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 2.56e-05 | 5 | 34 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | FACIT collagen trimer | 3.84e-05 | 6 | 34 | 2 | GO:0005593 | |
| GeneOntologyCellularComponent | basement membrane | 1.02e-03 | 122 | 34 | 3 | GO:0005604 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 5.31e-03 | 67 | 34 | 2 | GO:0098686 | |
| HumanPheno | Arthralgia of the hip | 1.38e-06 | 9 | 14 | 3 | HP:0003365 | |
| HumanPheno | Schmorl's node | 7.02e-06 | 2 | 14 | 2 | HP:0030041 | |
| HumanPheno | Knee pain | 1.10e-05 | 17 | 14 | 3 | HP:0030839 | |
| HumanPheno | Abnormal morphology of the radius | 1.26e-05 | 217 | 14 | 6 | HP:0002818 | |
| HumanPheno | Limb pain | 1.30e-05 | 57 | 14 | 4 | HP:0009763 | |
| HumanPheno | Hyperlordosis | 1.43e-05 | 222 | 14 | 6 | HP:0003307 | |
| HumanPheno | Lordosis | 1.43e-05 | 222 | 14 | 6 | HP:0002939 | |
| HumanPheno | Abnormal forearm bone morphology | 2.04e-05 | 236 | 14 | 6 | HP:0040072 | |
| HumanPheno | Fragmentation of the metacarpal epiphyses | 2.10e-05 | 3 | 14 | 2 | HP:0009189 | |
| HumanPheno | Fragmented epiphyses of the upper limbs | 2.10e-05 | 3 | 14 | 2 | HP:0003841 | |
| HumanPheno | Radially deviated wrists | 2.10e-05 | 3 | 14 | 2 | HP:0006190 | |
| HumanPheno | Abnormality of the epiphyses of the elbow | 2.10e-05 | 3 | 14 | 2 | HP:0003946 | |
| HumanPheno | Abnormal forearm morphology | 2.19e-05 | 239 | 14 | 6 | HP:0002973 | |
| HumanPheno | Osteoarthritis | 2.20e-05 | 65 | 14 | 4 | HP:0002758 | |
| HumanPheno | Malar flattening | 2.24e-05 | 240 | 14 | 6 | HP:0000272 | |
| HumanPheno | Vitreoretinopathy | 2.47e-05 | 22 | 14 | 3 | HP:0007773 | |
| HumanPheno | Coxa vara | 2.63e-05 | 68 | 14 | 4 | HP:0002812 | |
| HumanPheno | Abnormal malar bone morphology | 2.77e-05 | 249 | 14 | 6 | HP:0012369 | |
| HumanPheno | Abnormal zygomatic arch morphology | 2.83e-05 | 250 | 14 | 6 | HP:0005557 | |
| HumanPheno | Abnormal zygomatic bone morphology | 2.83e-05 | 250 | 14 | 6 | HP:0010668 | |
| HumanPheno | Small epiphyses | 3.23e-05 | 24 | 14 | 3 | HP:0010585 | |
| HumanPheno | Flattened epiphysis | 3.67e-05 | 25 | 14 | 3 | HP:0003071 | |
| HumanPheno | Irregular epiphyses | 3.67e-05 | 25 | 14 | 3 | HP:0010582 | |
| HumanPheno | Ulnar deviated club hands | 4.20e-05 | 4 | 14 | 2 | HP:0006055 | |
| HumanPheno | Abnormality of the distal femoral epiphysis | 4.20e-05 | 4 | 14 | 2 | HP:0010590 | |
| HumanPheno | Reduced arm span | 4.20e-05 | 4 | 14 | 2 | HP:0012770 | |
| HumanPheno | Abnormality of the elbow | 5.62e-05 | 282 | 14 | 6 | HP:0009811 | |
| HumanPheno | Epiphyseal dysplasia | 5.79e-05 | 29 | 14 | 3 | HP:0002656 | |
| HumanPheno | Irregular vertebral endplates | 6.42e-05 | 30 | 14 | 3 | HP:0003301 | |
| HumanPheno | Fragmented epiphyses | 6.98e-05 | 5 | 14 | 2 | HP:0100168 | |
| HumanPheno | Degenerative vitreoretinopathy | 6.98e-05 | 5 | 14 | 2 | HP:0007964 | |
| HumanPheno | Pierre-Robin sequence | 9.41e-05 | 34 | 14 | 3 | HP:0000201 | |
| HumanPheno | High myopia | 9.45e-05 | 94 | 14 | 4 | HP:0011003 | |
| HumanPheno | Abnormality of radial epiphyses | 1.05e-04 | 6 | 14 | 2 | HP:0003999 | |
| HumanPheno | Lumbar hyperlordosis | 1.16e-04 | 99 | 14 | 4 | HP:0002938 | |
| HumanPheno | Abnormal upper limb bone morphology | 1.27e-04 | 484 | 14 | 7 | HP:0040070 | |
| HumanPheno | Abnormality of the vertebral endplates | 1.32e-04 | 38 | 14 | 3 | HP:0005106 | |
| HumanPheno | Hypoplastic facial bones | 1.38e-04 | 331 | 14 | 6 | HP:0002692 | |
| HumanPheno | Aplasia/Hypoplasia of facial bones | 1.41e-04 | 332 | 14 | 6 | HP:0034261 | |
| HumanPheno | Abnormality of the epiphyses of the feet | 1.46e-04 | 7 | 14 | 2 | HP:0010631 | |
| HumanPheno | Lower limb pain | 1.66e-04 | 41 | 14 | 3 | HP:0012514 | |
| HumanPheno | Abnormal patella morphology | 1.68e-04 | 109 | 14 | 4 | HP:0003045 | |
| HumanPheno | Retinal detachment | 2.29e-04 | 118 | 14 | 4 | HP:0000541 | |
| HumanPheno | Abnormal vitreous humor morphology | 2.83e-04 | 49 | 14 | 3 | HP:0004327 | |
| HumanPheno | Intervertebral space narrowing | 3.12e-04 | 10 | 14 | 2 | HP:0002945 | |
| HumanPheno | Cigarette-paper scars | 3.12e-04 | 10 | 14 | 2 | HP:0001073 | |
| HumanPheno | Irregular femoral epiphysis | 3.12e-04 | 10 | 14 | 2 | HP:0006361 | |
| HumanPheno | Waddling gait | 3.32e-04 | 130 | 14 | 4 | HP:0002515 | |
| HumanPheno | Abnormal arm span | 3.80e-04 | 11 | 14 | 2 | HP:0012769 | |
| HumanPheno | Joint laxity | 3.99e-04 | 55 | 14 | 3 | HP:0001388 | |
| HumanPheno | Rhegmatogenous retinal detachment | 4.56e-04 | 12 | 14 | 2 | HP:0012230 | |
| HumanPheno | Radial deviation of the hand | 4.56e-04 | 12 | 14 | 2 | HP:0009486 | |
| HumanPheno | Abnormal hand epiphysis morphology | 4.91e-04 | 59 | 14 | 3 | HP:0005924 | |
| HumanPheno | Flat capital femoral epiphysis | 5.38e-04 | 13 | 14 | 2 | HP:0003370 | |
| HumanPheno | Bilateral coxa valga | 5.38e-04 | 13 | 14 | 2 | HP:0010665 | |
| HumanPheno | Genu varum | 5.42e-04 | 61 | 14 | 3 | HP:0002970 | |
| HumanPheno | Abnormal upper limb epiphysis morphology | 6.24e-04 | 64 | 14 | 3 | HP:0003839 | |
| HumanPheno | Postexertional symptom exacerbation | 6.26e-04 | 14 | 14 | 2 | HP:0030973 | |
| HumanPheno | Flattened femoral epiphysis | 6.26e-04 | 14 | 14 | 2 | HP:0030289 | |
| HumanPheno | Micrognathia | 6.41e-04 | 843 | 14 | 8 | HP:0000347 | |
| HumanPheno | Aplasia/Hypoplasia of the mandible | 6.52e-04 | 845 | 14 | 8 | HP:0009118 | |
| HumanPheno | Abnormal maxilla morphology | 6.99e-04 | 158 | 14 | 4 | HP:0000326 | |
| HumanPheno | Myopia | 7.19e-04 | 447 | 14 | 6 | HP:0000545 | |
| HumanPheno | Knee osteoarthritis | 7.22e-04 | 15 | 14 | 2 | HP:0005086 | |
| HumanPheno | Abnormal femoral neck morphology | 7.34e-04 | 160 | 14 | 4 | HP:0003367 | |
| HumanPheno | Midface retrusion | 7.67e-04 | 291 | 14 | 5 | HP:0011800 | |
| HumanPheno | Abnormal lower limb bone morphology | 7.74e-04 | 866 | 14 | 8 | HP:0040069 | |
| HumanPheno | Abnormal hip bone morphology | 8.36e-04 | 653 | 14 | 7 | HP:0003272 | |
| HumanPheno | Premature rupture of membranes | 9.32e-04 | 17 | 14 | 2 | HP:0001788 | |
| HumanPheno | Aplasia/Hypoplasia involving bones of the skull | 1.13e-03 | 915 | 14 | 8 | HP:0009116 | |
| HumanPheno | Abnormality of the knee | 1.19e-03 | 491 | 14 | 6 | HP:0002815 | |
| HumanPheno | Abnormal midface morphology | 1.33e-03 | 704 | 14 | 7 | HP:0000309 | |
| HumanPheno | Abnormal metacarpal epiphysis morphology | 1.43e-03 | 21 | 14 | 2 | HP:0005913 | |
| HumanPheno | Abnormality of the ankle | 1.45e-03 | 192 | 14 | 4 | HP:0003028 | |
| HumanPheno | Abnormal curvature of the vertebral column | COL2A1 POMGNT1 COL5A1 COL6A1 COL9A1 WNK1 RBM10 COL27A1 NECTIN1 | 1.52e-03 | 1219 | 14 | 9 | HP:0010674 |
| HumanPheno | Dystrophic toenail | 1.57e-03 | 22 | 14 | 2 | HP:0001810 | |
| HumanPheno | Abnormal pelvic girdle bone morphology | 1.65e-03 | 730 | 14 | 7 | HP:0002644 | |
| HumanPheno | Tibial torsion | 1.72e-03 | 23 | 14 | 2 | HP:0100694 | |
| HumanPheno | Abnormal femoral neck/head morphology | 1.72e-03 | 201 | 14 | 4 | HP:0003366 | |
| HumanPheno | Coxa valga | 1.80e-03 | 92 | 14 | 3 | HP:0002673 | |
| HumanPheno | Hypoplasia of the capital femoral epiphysis | 1.87e-03 | 24 | 14 | 2 | HP:0003090 | |
| HumanPheno | Aplasia/Hypoplasia of the capital femoral epiphysis | 1.87e-03 | 24 | 14 | 2 | HP:0005003 | |
| HumanPheno | Abnormal lower limb epiphysis morphology | 1.91e-03 | 94 | 14 | 3 | HP:0006500 | |
| HumanPheno | Arthralgia | 1.92e-03 | 207 | 14 | 4 | HP:0002829 | |
| HumanPheno | Absent epiphyses | 2.03e-03 | 25 | 14 | 2 | HP:0010577 | |
| HumanPheno | Abnormality of the joints of the lower limbs | 2.10e-03 | 547 | 14 | 6 | HP:0100239 | |
| HumanPheno | Abnormal knee morphology | 2.12e-03 | 364 | 14 | 5 | HP:0034669 | |
| HumanPheno | Aplasia/hypoplasia affecting bones of the axial skeleton | 2.20e-03 | 1008 | 14 | 8 | HP:0009122 | |
| HumanPheno | Protruding ear | 2.37e-03 | 219 | 14 | 4 | HP:0000411 | |
| HumanPheno | Small earlobe | 2.37e-03 | 27 | 14 | 2 | HP:0000385 | |
| HumanPheno | Flat face | 2.70e-03 | 106 | 14 | 3 | HP:0012368 | |
| MousePheno | abnormal chondrocyte physiology | 7.84e-05 | 42 | 28 | 3 | MP:0009780 | |
| MousePheno | retrognathia | 8.07e-05 | 7 | 28 | 2 | MP:0004282 | |
| MousePheno | abnormal cartilage physiology | 8.42e-05 | 43 | 28 | 3 | MP:0031306 | |
| MousePheno | abnormal ciliary process morphology | 1.38e-04 | 9 | 28 | 2 | MP:0014164 | |
| Domain | Collagen | COL2A1 COL5A1 COL6A1 COL24A1 OTOL1 COL9A1 COL9A2 C1QTNF3 COL6A6 COL27A1 | 1.31e-16 | 85 | 32 | 10 | PF01391 |
| Domain | Collagen | COL2A1 COL5A1 COL6A1 COL24A1 OTOL1 COL9A1 COL9A2 C1QTNF3 COL6A6 COL27A1 | 1.31e-16 | 85 | 32 | 10 | IPR008160 |
| Domain | NC1_FIB | 2.32e-09 | 11 | 32 | 4 | PS51461 | |
| Domain | Fib_collagen_C | 2.32e-09 | 11 | 32 | 4 | IPR000885 | |
| Domain | Fib_collagen_C | 2.32e-09 | 11 | 32 | 4 | PD002078 | |
| Domain | COLFI | 2.32e-09 | 11 | 32 | 4 | SM00038 | |
| Domain | COLFI | 2.32e-09 | 11 | 32 | 4 | PF01410 | |
| Domain | TSPN | 6.14e-08 | 23 | 32 | 4 | SM00210 | |
| Domain | Laminin_G | 2.82e-06 | 58 | 32 | 4 | IPR001791 | |
| Domain | ConA-like_dom | 3.29e-05 | 219 | 32 | 5 | IPR013320 | |
| Domain | LAM_G_DOMAIN | 3.70e-05 | 38 | 32 | 3 | PS50025 | |
| Domain | VWA | 1.19e-04 | 56 | 32 | 3 | PF00092 | |
| Domain | VWFA | 3.69e-04 | 82 | 32 | 3 | PS50234 | |
| Domain | VWA | 3.96e-04 | 84 | 32 | 3 | SM00327 | |
| Domain | - | 5.68e-04 | 95 | 32 | 3 | 2.60.120.200 | |
| Domain | VWF_A | 6.41e-04 | 99 | 32 | 3 | IPR002035 | |
| Domain | G_patch | 7.04e-04 | 23 | 32 | 2 | SM00443 | |
| Domain | G_patch_dom | 7.04e-04 | 23 | 32 | 2 | IPR000467 | |
| Domain | G-patch | 7.04e-04 | 23 | 32 | 2 | PF01585 | |
| Domain | G_PATCH | 7.04e-04 | 23 | 32 | 2 | PS50174 | |
| Domain | C1Q | 1.37e-03 | 32 | 32 | 2 | SM00110 | |
| Domain | C1q | 1.37e-03 | 32 | 32 | 2 | PF00386 | |
| Domain | C1q_dom | 1.54e-03 | 34 | 32 | 2 | IPR001073 | |
| Domain | C1Q | 1.54e-03 | 34 | 32 | 2 | PS50871 | |
| Domain | Laminin_G_2 | 2.13e-03 | 40 | 32 | 2 | PF02210 | |
| Domain | CUB | 3.18e-03 | 49 | 32 | 2 | PF00431 | |
| Domain | - | 3.31e-03 | 50 | 32 | 2 | 2.60.120.40 | |
| Domain | CUB | 3.31e-03 | 50 | 32 | 2 | SM00042 | |
| Domain | - | 3.57e-03 | 52 | 32 | 2 | 2.60.120.290 | |
| Domain | CUB | 3.71e-03 | 53 | 32 | 2 | PS01180 | |
| Domain | CUB_dom | 4.28e-03 | 57 | 32 | 2 | IPR000859 | |
| Domain | Tumour_necrosis_fac-like_dom | 4.43e-03 | 58 | 32 | 2 | IPR008983 | |
| Domain | - | 7.11e-03 | 74 | 32 | 2 | 3.40.50.410 | |
| Domain | TRYPSIN_SER | 1.04e-02 | 90 | 32 | 2 | IPR033116 | |
| Domain | TRYPSIN_HIS | 1.34e-02 | 103 | 32 | 2 | IPR018114 | |
| Domain | TRYPSIN_SER | 1.42e-02 | 106 | 32 | 2 | PS00135 | |
| Domain | TRYPSIN_HIS | 1.44e-02 | 107 | 32 | 2 | PS00134 | |
| Domain | Peptidase_S1A | 1.60e-02 | 113 | 32 | 2 | IPR001314 | |
| Domain | TRYPSIN_DOM | 1.65e-02 | 115 | 32 | 2 | PS50240 | |
| Domain | Tryp_SPc | 1.71e-02 | 117 | 32 | 2 | SM00020 | |
| Domain | Trypsin | 1.82e-02 | 121 | 32 | 2 | PF00089 | |
| Domain | Trypsin_dom | 1.82e-02 | 121 | 32 | 2 | IPR001254 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 9.76e-15 | 44 | 27 | 8 | M27812 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.59e-13 | 61 | 27 | 8 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.49e-13 | 67 | 27 | 8 | M26999 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.04e-12 | 20 | 27 | 6 | MM15061 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.04e-12 | 90 | 27 | 8 | M631 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 7.20e-11 | 38 | 27 | 6 | MM14969 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.17e-10 | 41 | 27 | 6 | MM15538 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.36e-10 | 42 | 27 | 6 | M7169 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.77e-10 | 47 | 27 | 6 | MM14925 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.08e-10 | 50 | 27 | 6 | MM14796 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 9.24e-10 | 57 | 27 | 6 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.03e-09 | 58 | 27 | 6 | M2049 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.41e-09 | 61 | 27 | 6 | MM14637 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.72e-09 | 63 | 27 | 6 | M11187 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.89e-09 | 64 | 27 | 6 | M26953 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 5.43e-09 | 76 | 27 | 6 | MM14573 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.43e-09 | 76 | 27 | 6 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.43e-09 | 76 | 27 | 6 | MM14867 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 1.07e-08 | 85 | 27 | 6 | M16441 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 2.26e-08 | 46 | 27 | 5 | M198 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.99e-08 | 300 | 27 | 8 | M610 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.15e-07 | 140 | 27 | 6 | M587 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.56e-07 | 74 | 27 | 5 | M160 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.83e-07 | 30 | 27 | 4 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.03e-06 | 41 | 27 | 4 | M27778 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.93e-06 | 53 | 27 | 4 | MM14566 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 4.59e-06 | 532 | 27 | 8 | M27870 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 7.60e-06 | 258 | 27 | 6 | MM14572 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 8.12e-06 | 261 | 27 | 6 | MM15676 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.45e-05 | 79 | 27 | 4 | M27643 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.85e-05 | 84 | 27 | 4 | M7098 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 3.33e-05 | 502 | 27 | 7 | MM14537 | |
| Pathway | WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES | 5.27e-05 | 6 | 27 | 2 | M39872 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.17e-05 | 114 | 27 | 4 | MM14571 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.14e-04 | 418 | 27 | 6 | MM15587 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.65e-04 | 66 | 27 | 3 | M18 | |
| Pathway | WP_PI3KAKT_SIGNALING | 4.08e-04 | 339 | 27 | 5 | M39736 | |
| Pathway | KEGG_FOCAL_ADHESION | 5.24e-04 | 199 | 27 | 4 | M7253 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 5.92e-04 | 19 | 27 | 2 | MM15512 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 6.38e-04 | 575 | 27 | 6 | M29853 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.49e-03 | 30 | 27 | 2 | MM15517 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.69e-03 | 32 | 27 | 2 | MM14924 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 3.04e-03 | 43 | 27 | 2 | M39565 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 5.65e-03 | 59 | 27 | 2 | M27218 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 7.23e-03 | 67 | 27 | 2 | MM15345 | |
| Pubmed | 1.92e-13 | 10 | 35 | 5 | 2446864 | ||
| Pubmed | 4.32e-10 | 175 | 35 | 7 | 28071719 | ||
| Pubmed | Collagen type IX from human cartilage: a structural profile of intermolecular cross-linking sites. | 3.73e-09 | 4 | 35 | 3 | 8660302 | |
| Pubmed | 3.73e-09 | 4 | 35 | 3 | 11724554 | ||
| Pubmed | 9.59e-09 | 153 | 35 | 6 | 25037231 | ||
| Pubmed | 1.07e-08 | 25 | 35 | 4 | 19180518 | ||
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 8305476 | ||
| Pubmed | Expression patterns of cartilage collagens and Sox9 during mouse heart development. | 1.86e-08 | 6 | 35 | 3 | 12883905 | |
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 15922184 | ||
| Pubmed | 1.86e-08 | 6 | 35 | 3 | 20301479 | ||
| Pubmed | Type II and type IX collagen transcript isoforms are expressed during mouse testis development. | 3.26e-08 | 7 | 35 | 3 | 12606408 | |
| Pubmed | Structure, chromosomal location, and tissue-specific expression of the mouse opticin gene. | 3.26e-08 | 7 | 35 | 3 | 11527931 | |
| Pubmed | 3.26e-08 | 7 | 35 | 3 | 9426396 | ||
| Pubmed | 5.21e-08 | 8 | 35 | 3 | 9164858 | ||
| Pubmed | 7.81e-08 | 9 | 35 | 3 | 8900172 | ||
| Pubmed | Roles of cell-adhesion molecules nectin 1 and nectin 3 in ciliary body development. | 1.11e-07 | 10 | 35 | 3 | 15728677 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 2.42e-07 | 135 | 35 | 5 | 28675934 | |
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 4.21e-07 | 15 | 35 | 3 | 9832566 | |
| Pubmed | Perlecan maintains the integrity of cartilage and some basement membranes. | 4.21e-07 | 15 | 35 | 3 | 10579729 | |
| Pubmed | Maturational disturbance of chondrocytes in Cbfa1-deficient mice. | 6.29e-07 | 17 | 35 | 3 | 10213384 | |
| Pubmed | Mice lacking alpha 1 (IX) collagen develop noninflammatory degenerative joint disease. | 9.84e-07 | 2 | 35 | 2 | 8197187 | |
| Pubmed | 9.84e-07 | 2 | 35 | 2 | 9707347 | ||
| Pubmed | 1.86e-06 | 24 | 35 | 3 | 25344368 | ||
| Pubmed | 2.14e-06 | 210 | 35 | 5 | 16537572 | ||
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 2.69e-06 | 27 | 35 | 3 | 12192060 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 2.79e-06 | 97 | 35 | 4 | 27559042 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 27628582 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 26429145 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 15908193 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 20358595 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 17024418 | ||
| Pubmed | Identification of a novel common genetic risk factor for lumbar disk disease. | 2.95e-06 | 3 | 35 | 2 | 11308397 | |
| Pubmed | The NC2 domain of type IX collagen determines the chain register of the triple helix. | 2.95e-06 | 3 | 35 | 2 | 23132862 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 32068261 | ||
| Pubmed | Structural insight for chain selection and stagger control in collagen. | 2.95e-06 | 3 | 35 | 2 | 27897211 | |
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 1429648 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 31090205 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 17331945 | ||
| Pubmed | 2.95e-06 | 3 | 35 | 2 | 30577800 | ||
| Pubmed | Structure of the glycosaminoglycan domain in the type IX collagen-proteoglycan. | 2.95e-06 | 3 | 35 | 2 | 3473493 | |
| Pubmed | Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse. | 5.90e-06 | 4 | 35 | 2 | 17683922 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 1544908 | ||
| Pubmed | Interactions between collagen gene variants and risk of anterior cruciate ligament rupture. | 5.90e-06 | 4 | 35 | 2 | 25073002 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 12874293 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 15562585 | ||
| Pubmed | Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs. | 5.90e-06 | 4 | 35 | 2 | 2054384 | |
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 8244386 | ||
| Pubmed | 5.90e-06 | 4 | 35 | 2 | 23530037 | ||
| Pubmed | Mutations in collagen genes resulting in metaphyseal and epiphyseal dysplasias. | 5.90e-06 | 4 | 35 | 2 | 8579897 | |
| Pubmed | A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity. | 5.90e-06 | 4 | 35 | 2 | 11565064 | |
| Pubmed | 7.69e-06 | 38 | 35 | 3 | 25572963 | ||
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 11973338 | ||
| Pubmed | Intervertebral disc degeneration in relation to the COL9A3 and the IL-1ss gene polymorphisms. | 9.82e-06 | 5 | 35 | 2 | 16133074 | |
| Pubmed | Differential and restricted expression of novel collagen VI chains in mouse. | 9.82e-06 | 5 | 35 | 2 | 21477648 | |
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 18448257 | ||
| Pubmed | The expanded collagen VI family: new chains and new questions. | 9.82e-06 | 5 | 35 | 2 | 23869615 | |
| Pubmed | 9.82e-06 | 5 | 35 | 2 | 20301302 | ||
| Pubmed | 1.20e-05 | 44 | 35 | 3 | 21308778 | ||
| Pubmed | The Type 3 Deiodinase Is a Critical Modulator of Thyroid Hormone Sensitivity in the Fetal Brain. | 1.29e-05 | 45 | 35 | 3 | 34248495 | |
| Pubmed | ADAMTS3 activity is mandatory for embryonic lymphangiogenesis and regulates placental angiogenesis. | 1.29e-05 | 45 | 35 | 3 | 26446156 | |
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 21467034 | ||
| Pubmed | ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. | 1.47e-05 | 6 | 35 | 2 | 17029294 | |
| Pubmed | The role of collagen II and cartilage fibril-associated molecules in skeletal development. | 1.47e-05 | 6 | 35 | 2 | 11680679 | |
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 1.47e-05 | 6 | 35 | 2 | 8563024 | |
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 17876790 | ||
| Pubmed | Retarded skeletal development in transgenic mice with a type II collagen mutation. | 1.47e-05 | 6 | 35 | 2 | 8952549 | |
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 17359303 | ||
| Pubmed | Interaction of human thrombospondin with types I-V collagen: direct binding and electron microscopy. | 1.47e-05 | 6 | 35 | 2 | 3571333 | |
| Pubmed | 1.47e-05 | 6 | 35 | 2 | 15523498 | ||
| Pubmed | 1.77e-05 | 50 | 35 | 3 | 23658023 | ||
| Pubmed | Three novel collagen VI chains with high homology to the alpha3 chain. | 2.06e-05 | 7 | 35 | 2 | 18276594 | |
| Pubmed | Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. | 2.06e-05 | 7 | 35 | 2 | 9334230 | |
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 12847218 | ||
| Pubmed | 2.06e-05 | 7 | 35 | 2 | 9501082 | ||
| Pubmed | Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis. | 2.06e-05 | 7 | 35 | 2 | 23001182 | |
| Pubmed | Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI). | 2.06e-05 | 7 | 35 | 2 | 18400749 | |
| Pubmed | 2.39e-05 | 167 | 35 | 4 | 22159717 | ||
| Pubmed | Subtypes of medulloblastoma have distinct developmental origins. | 2.63e-05 | 57 | 35 | 3 | 21150899 | |
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 2.74e-05 | 8 | 35 | 2 | 20059976 | |
| Pubmed | Wnt signaling mediates regional specification in the vertebrate face. | 2.74e-05 | 8 | 35 | 2 | 17699607 | |
| Pubmed | Odd-skipped related-1 controls neural crest chondrogenesis during tongue development. | 2.74e-05 | 8 | 35 | 2 | 24167250 | |
| Pubmed | 2.74e-05 | 8 | 35 | 2 | 15872058 | ||
| Pubmed | A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16. | 2.74e-05 | 8 | 35 | 2 | 24563484 | |
| Pubmed | In vivo evidence for a bridging role of a collagen V subtype at the epidermis-dermis interface. | 2.74e-05 | 8 | 35 | 2 | 22437311 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 3.39e-05 | 62 | 35 | 3 | 28344315 | |
| Pubmed | Collagen XXVII organises the pericellular matrix in the growth plate. | 3.53e-05 | 9 | 35 | 2 | 22206015 | |
| Pubmed | Med23 Regulates Sox9 Expression during Craniofacial Development. | 4.40e-05 | 10 | 35 | 2 | 33155500 | |
| Pubmed | 4.40e-05 | 10 | 35 | 2 | 27666725 | ||
| Pubmed | 4.40e-05 | 10 | 35 | 2 | 10886375 | ||
| Pubmed | The extracellular matrix gene Frem1 is essential for the normal adhesion of the embryonic epidermis. | 4.40e-05 | 10 | 35 | 2 | 15345741 | |
| Pubmed | 5.38e-05 | 11 | 35 | 2 | 9664687 | ||
| Pubmed | 5.38e-05 | 11 | 35 | 2 | 2745554 | ||
| Pubmed | 5.38e-05 | 11 | 35 | 2 | 22242143 | ||
| Pubmed | 5.38e-05 | 11 | 35 | 2 | 23095887 | ||
| Pubmed | 6.45e-05 | 12 | 35 | 2 | 36449606 | ||
| Pubmed | TAZ is required for chondrogenesis and skeletal development. | 6.45e-05 | 12 | 35 | 2 | 33879790 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 6.47e-05 | 701 | 35 | 6 | 30196744 | |
| Pubmed | Indian hedgehog signals independently of PTHrP to promote chondrocyte hypertrophy. | 7.62e-05 | 13 | 35 | 2 | 18434416 | |
| Pubmed | 8.89e-05 | 14 | 35 | 2 | 23238123 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 9.02e-05 | 86 | 35 | 3 | 28327460 | |
| Interaction | MAG interactions | 9.90e-10 | 29 | 33 | 5 | int:MAG | |
| Interaction | C1QC interactions | 6.38e-07 | 42 | 33 | 4 | int:C1QC | |
| Interaction | COL9A1 interactions | 1.13e-06 | 13 | 33 | 3 | int:COL9A1 | |
| Interaction | COL2A1 interactions | 3.53e-06 | 64 | 33 | 4 | int:COL2A1 | |
| Interaction | COLGALT2 interactions | 4.25e-06 | 67 | 33 | 4 | int:COLGALT2 | |
| Interaction | PDGFA interactions | 1.92e-05 | 32 | 33 | 3 | int:PDGFA | |
| Interaction | COL8A2 interactions | 4.40e-05 | 42 | 33 | 3 | int:COL8A2 | |
| Interaction | C1QTNF1 interactions | 6.18e-05 | 47 | 33 | 3 | int:C1QTNF1 | |
| Interaction | LOC102724334 interactions | 6.58e-05 | 134 | 33 | 4 | int:LOC102724334 | |
| Interaction | LAIR2 interactions | 7.00e-05 | 49 | 33 | 3 | int:LAIR2 | |
| Interaction | C1QTNF2 interactions | 1.42e-04 | 62 | 33 | 3 | int:C1QTNF2 | |
| Interaction | HAS1 interactions | 1.42e-04 | 11 | 33 | 2 | int:HAS1 | |
| Interaction | MMP9 interactions | 1.78e-04 | 67 | 33 | 3 | int:MMP9 | |
| Interaction | H2BC18 interactions | 2.06e-04 | 180 | 33 | 4 | int:H2BC18 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 1.46e-03 | 294 | 35 | 3 | chr1p34 | |
| Cytoband | 21q22.3 | 4.32e-03 | 128 | 35 | 2 | 21q22.3 | |
| GeneFamily | Collagens | 1.83e-16 | 46 | 21 | 8 | 490 | |
| GeneFamily | Collagens|Collagen proteoglycans | 1.28e-05 | 5 | 21 | 2 | 575 | |
| GeneFamily | Endogenous ligands|C1q and TNF related | 1.94e-04 | 18 | 21 | 2 | 1372 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 2.93e-04 | 22 | 21 | 2 | 579 | |
| Coexpression | NABA_COLLAGENS | 4.63e-16 | 43 | 34 | 8 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 5.65e-16 | 44 | 34 | 8 | M3005 | |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL5A1 COL6A1 COL24A1 OTOL1 COL9A1 COL9A2 COL6A6 COL27A1 | 4.79e-11 | 270 | 34 | 9 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL5A1 COL6A1 COL24A1 OTOL1 COL9A1 COL9A2 COL6A6 COL27A1 | 5.64e-11 | 275 | 34 | 9 | M5884 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE | 6.14e-09 | 111 | 34 | 6 | M45685 | |
| Coexpression | NABA_MATRISOME | COL2A1 COL5A1 COL6A1 COL24A1 OTOL1 COL9A1 COL9A2 C1QTNF3 COL6A6 COL27A1 MASP2 | 3.27e-08 | 1008 | 34 | 11 | MM17056 |
| Coexpression | NABA_MATRISOME | COL2A1 COL5A1 COL6A1 COL24A1 OTOL1 COL9A1 COL9A2 C1QTNF3 COL6A6 COL27A1 MASP2 | 3.92e-08 | 1026 | 34 | 11 | M5889 |
| Coexpression | DESCARTES_ORGANOGENESIS_JAW_AND_TOOTH_PROGENITORS | 4.35e-07 | 12 | 34 | 3 | MM3646 | |
| Coexpression | KANG_AR_TARGETS_UP | 1.34e-06 | 17 | 34 | 3 | M2223 | |
| Coexpression | KANG_AR_TARGETS_UP | 1.34e-06 | 17 | 34 | 3 | MM1297 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 7.12e-06 | 29 | 34 | 3 | MM17055 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 8.24e-05 | 65 | 34 | 3 | M39309 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE | 9.43e-05 | 68 | 34 | 3 | M45669 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.07e-04 | 71 | 34 | 3 | M3955 | |
| Coexpression | GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_DN | 1.11e-04 | 193 | 34 | 4 | M9966 | |
| Coexpression | GSE557_WT_VS_CIITA_KO_DC_DN | 1.28e-04 | 200 | 34 | 4 | M6008 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.43e-04 | 206 | 34 | 4 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.48e-04 | 208 | 34 | 4 | MM581 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 2.24e-04 | 91 | 34 | 3 | M40180 | |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 2.87e-04 | 99 | 34 | 3 | M39152 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL | 3.32e-04 | 104 | 34 | 3 | M45682 | |
| Coexpression | JACKSON_DNMT1_TARGETS_DN | 3.38e-04 | 21 | 34 | 2 | MM1196 | |
| Coexpression | DESCARTES_MAIN_FETAL_STROMAL_CELLS | 3.71e-04 | 22 | 34 | 2 | M40074 | |
| Coexpression | JACKSON_DNMT1_TARGETS_DN | 3.71e-04 | 22 | 34 | 2 | M1627 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 4.09e-04 | 493 | 34 | 5 | M19391 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE | 4.69e-04 | 117 | 34 | 3 | M45663 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 4.69e-04 | 117 | 34 | 3 | M39300 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.05e-11 | 166 | 34 | 7 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.05e-11 | 166 | 34 | 7 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 9.72e-11 | 188 | 34 | 7 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-10 | 191 | 34 | 7 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-10 | 198 | 34 | 7 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-10 | 198 | 34 | 7 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-10 | 198 | 34 | 7 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.17e-09 | 169 | 34 | 6 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.04e-09 | 176 | 34 | 6 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | Mesenchymal_cells-Chondrocytes|Mesenchymal_cells / Lineage and Cell class | 4.62e-09 | 180 | 34 | 6 | 6e399368430ef3afa9ce1ef0ed90f614ccef9987 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.00e-09 | 188 | 34 | 6 | 5a89587ee6f2b4dc14244bd88bb31efb81c50dbe | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.19e-09 | 189 | 34 | 6 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.19e-09 | 189 | 34 | 6 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | (3)_Chondrocytes|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 6.80e-09 | 192 | 34 | 6 | 5d2b4830d025d3dbdf5623ce1c28d1036e1984a8 | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 7.93e-09 | 197 | 34 | 6 | a07ab2564ca7d577fd47f444dd7b0c25556e9fc4 | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-09 | 199 | 34 | 6 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| ToppCell | 18-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 8.42e-09 | 199 | 34 | 6 | f5d0aa4170367c080d3c2f01d9af3529762917fa | |
| ToppCell | droplet-Trachea|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-09 | 199 | 34 | 6 | b9038a1ccf3ef3123e2e39afbe6213c363437443 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.55e-07 | 164 | 34 | 5 | a764b79a127c8f360af0b79a1da64658badf0dfa | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-07 | 167 | 34 | 5 | 7b1fd19946cee67dae68f0f0d98420abcd532482 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.69e-07 | 167 | 34 | 5 | 102b3d160a44c8623fab1fd10e9054178c42a78b | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-07 | 173 | 34 | 5 | 2226505610af1becc253d0a5550627144ef0ed6b | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.13e-07 | 175 | 34 | 5 | f1394aacc8a94ca555dd19aaed5a18da99c6bf40 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.13e-07 | 175 | 34 | 5 | 7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.26e-07 | 177 | 34 | 5 | b01d7a6a78169962123ddfb0bb588f51d138ad02 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.32e-07 | 178 | 34 | 5 | 8591a40fced747ac16b3e8ebc7a22dfb3ad76da2 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.59e-07 | 182 | 34 | 5 | 03a5a02acd48f0eb210485348bfe0cd21f486215 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.74e-07 | 184 | 34 | 5 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 2.74e-07 | 184 | 34 | 5 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.81e-07 | 185 | 34 | 5 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.81e-07 | 185 | 34 | 5 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.89e-07 | 186 | 34 | 5 | 80a0a42ca8585cdb1dda57a18c254316a126ee64 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.97e-07 | 187 | 34 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | (3)_Chondrocytes-(31)_Chondro-hyper|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.13e-07 | 189 | 34 | 5 | 394b153393904c3dba51a6bfe338afd554e66649 | |
| ToppCell | (3)_Chondrocytes-(31)_Chondro-hyper|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.13e-07 | 189 | 34 | 5 | 864526ed3e338c0353d10699f650f88c065ce72b | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.29e-07 | 191 | 34 | 5 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | 11.5-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 3.47e-07 | 193 | 34 | 5 | d4779d92a4dd4b8b656383e6f4fce76d3bd70931 | |
| ToppCell | 18-Distal-Mesenchymal-Cartilage|Distal / Age, Tissue, Lineage and Cell class | 3.47e-07 | 193 | 34 | 5 | 52f3d1bb8d8ca91ba12439d46392f377928ff8f8 | |
| ToppCell | (3)_Chondrocytes-(33)_Chondro-prol/rest|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.56e-07 | 194 | 34 | 5 | c093c5e161b97ad770bfbaad3023eba4537101b5 | |
| ToppCell | 15-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 3.65e-07 | 195 | 34 | 5 | 414f60bc0f0d0ecb5137bcd617fae91f0c15038a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.74e-07 | 196 | 34 | 5 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 3.74e-07 | 196 | 34 | 5 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.84e-07 | 197 | 34 | 5 | 6e111ba16fc8adde782b3f7da250248cddf11228 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.84e-07 | 197 | 34 | 5 | ece0c17eb68f394b20e588c0b0626d3987a4dbbb | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.84e-07 | 197 | 34 | 5 | 4b6c0e028b9669c102df8e9dc63e284f8d5fd9ee | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic-Chondrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.94e-07 | 198 | 34 | 5 | 55f013e9e6587d9ece59751fa131b1d22d6cceea | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-07 | 198 | 34 | 5 | 71e847e8c24744d6df4a960348ad2ecf310373b4 | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.94e-07 | 198 | 34 | 5 | c72ef2ddcbb6dacbed4c6200d89e17d57314dcdc | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.94e-07 | 198 | 34 | 5 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.94e-07 | 198 | 34 | 5 | 3575620db5aeaeb0bdcd7a8ff65c43abd3fa13e4 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.04e-07 | 199 | 34 | 5 | da016849b804fbf80edbfa8f8f56c9df8bbf2d51 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.14e-07 | 200 | 34 | 5 | be527df943a8cedc6452ecef3cafc282db34ceb8 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.14e-07 | 200 | 34 | 5 | c935caef2988f165e96d8f1ef99ae8963ab9377f | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.14e-07 | 200 | 34 | 5 | d254f6634895486f81d7a8b6f006fbc2679eaa5b | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.14e-07 | 200 | 34 | 5 | 8e41a484038216f0c2ad258fd46c0e702a4bb8bf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c02-NCAM1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.25e-06 | 158 | 34 | 4 | 4d997efc36fd8946775fe74dd9ac9ccd5ade64ff | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.74e-06 | 161 | 34 | 4 | 9703b7e67d9fadb6129cad166bd01be915042e44 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 7.25e-06 | 164 | 34 | 4 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.55e-06 | 171 | 34 | 4 | d2938639e9a7c349e5a6ec61724222f9d127c89f | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-06 | 173 | 34 | 4 | 3059325901b1e5e12a1a91183f14267288b2f600 | |
| ToppCell | -Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 8.95e-06 | 173 | 34 | 4 | 88be9182fbb1bc83531cd41e59ea57c112a21d54 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.95e-06 | 173 | 34 | 4 | 36c8338463ee4cc432f568728d55989360f9a68d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.36e-06 | 175 | 34 | 4 | 8b498eea1ec1c1f27b171025c3d08adf3687bafc | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 9.36e-06 | 175 | 34 | 4 | a84965d28438a4228d841b357c2cd75cf4b59a63 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.36e-06 | 175 | 34 | 4 | a5db428b078938627e61b7e944c1e0c1d61ac2da | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.36e-06 | 175 | 34 | 4 | 085cceb1fc2c4ae2f27e85cea5702defecc2cf44 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.79e-06 | 177 | 34 | 4 | 915b848d789051a1c3bc6f6dc86955bb752276ab | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.00e-05 | 178 | 34 | 4 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | (3)_Chondrocytes-(32)_Chondro-prehyper-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.00e-05 | 178 | 34 | 4 | c569a406c3ae183a278d8540e8eba58f4f26c5b0 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 181 | 34 | 4 | 8950844b3e65c7028d80da5787ae2ce509c3d52d | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.09e-05 | 182 | 34 | 4 | bb7de0c93d8f59f13c990e425139b9348ca8027e | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.09e-05 | 182 | 34 | 4 | 507f095af4dff60f2c2b64d750477154084c3595 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.09e-05 | 182 | 34 | 4 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.09e-05 | 182 | 34 | 4 | ed487f3a774812caa2903a646b60c86edcc1e65e | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.09e-05 | 182 | 34 | 4 | 88bd17c07bd8443a0ede4e9dc7bc9d1230b42211 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.09e-05 | 182 | 34 | 4 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.14e-05 | 184 | 34 | 4 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.17e-05 | 185 | 34 | 4 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.22e-05 | 187 | 34 | 4 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-05 | 188 | 34 | 4 | 9d384c0934f1461bc37b1f83e0877d7bee2116ee | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-05 | 188 | 34 | 4 | 340f0e3e65c7a00d82d26621ff37107458bebc41 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.24e-05 | 188 | 34 | 4 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.24e-05 | 188 | 34 | 4 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.24e-05 | 188 | 34 | 4 | 9b95730ddd13eb4624321bab3ab4989414977ca3 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.27e-05 | 189 | 34 | 4 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.27e-05 | 189 | 34 | 4 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.32e-05 | 191 | 34 | 4 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.32e-05 | 191 | 34 | 4 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.32e-05 | 191 | 34 | 4 | f9a46956778a8773d6656340ecf5d218376d79c2 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.35e-05 | 192 | 34 | 4 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.35e-05 | 192 | 34 | 4 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.35e-05 | 192 | 34 | 4 | 3a6f2c255da46a0b0f5b657b0f56f3d7798ae85a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.38e-05 | 193 | 34 | 4 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.40e-05 | 194 | 34 | 4 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.40e-05 | 194 | 34 | 4 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.40e-05 | 194 | 34 | 4 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 195 | 34 | 4 | b0d408f8bc1701a87596ed55efcd90749fee33e6 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 195 | 34 | 4 | 18b01ab63ee1deae3cf29669d66fff9ca4efc5c4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-05 | 195 | 34 | 4 | a486a7acea0e91048cc48afa0dbd3926d30bc217 | |
| ToppCell | P07-Mesenchymal|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.43e-05 | 195 | 34 | 4 | 859764b605866b6c3e6edd0698670ca9c0f20745 | |
| Computational | Adhesion molecules. | 1.73e-04 | 141 | 22 | 4 | MODULE_122 | |
| Drug | GK-101 | 6.93e-14 | 36 | 34 | 7 | CID000161853 | |
| Drug | Madecassol | 4.40e-13 | 46 | 34 | 7 | CID000108062 | |
| Drug | d-indobufen | 8.17e-13 | 50 | 34 | 7 | CID000044562 | |
| Drug | ridogrel | 1.09e-12 | 52 | 34 | 7 | CID005362391 | |
| Drug | NSC49633 | 1.26e-12 | 53 | 34 | 7 | CID000023340 | |
| Drug | AC1LAKND | 3.97e-12 | 62 | 34 | 7 | CID000470146 | |
| Drug | BAPN | 1.06e-11 | 71 | 34 | 7 | CID000001647 | |
| Drug | malotilate | 1.06e-11 | 71 | 34 | 7 | CID000004006 | |
| Drug | AC1NMZ1B | 1.58e-11 | 75 | 34 | 7 | CID005034185 | |
| Drug | strontium ranelate | 1.91e-11 | 77 | 34 | 7 | CID006918182 | |
| Drug | halofuginone lactate | 3.89e-11 | 85 | 34 | 7 | CID000062891 | |
| Drug | 4-hydroxyproline | 6.35e-11 | 91 | 34 | 7 | CID000000825 | |
| Drug | ticlopidine | 1.53e-10 | 103 | 34 | 7 | CID000005472 | |
| Drug | hydroxylysine | 2.29e-10 | 109 | 34 | 7 | CID000001029 | |
| Drug | AC1L1C2F | 2.45e-10 | 110 | 34 | 7 | CID000001711 | |
| Drug | PPACK | 2.96e-10 | 113 | 34 | 7 | CID003036757 | |
| Drug | foscarnet | 3.06e-10 | 190 | 34 | 8 | CID000003414 | |
| Drug | AC1L9732 | 3.15e-10 | 114 | 34 | 7 | CID000439300 | |
| Drug | Tranilast sodium | 3.35e-10 | 115 | 34 | 7 | CID000005527 | |
| Drug | Selara | 6.04e-10 | 125 | 34 | 7 | CID000150310 | |
| Drug | DMSe | 8.85e-10 | 132 | 34 | 7 | CID000020796 | |
| Drug | pirfenidone | 1.21e-09 | 138 | 34 | 7 | CID000040632 | |
| Drug | DL-penicillamine | 1.27e-09 | 139 | 34 | 7 | CID000004727 | |
| Drug | PCR 4099 | 1.27e-09 | 139 | 34 | 7 | CID000002806 | |
| Drug | candesartan cilexetil | 1.71e-09 | 145 | 34 | 7 | CID000002540 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 3.71e-09 | 162 | 34 | 7 | CID000072363 | |
| Drug | khellin | 5.40e-09 | 171 | 34 | 7 | CID000003828 | |
| Drug | NC-4 | 5.69e-09 | 44 | 34 | 5 | CID006420119 | |
| Drug | pyridinoline | 7.07e-09 | 99 | 34 | 6 | CID000105068 | |
| Drug | AC1L1DD6 | 7.42e-09 | 179 | 34 | 7 | CID000002299 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 1.08e-08 | 189 | 34 | 7 | CID000001413 | |
| Drug | NSC-333492 | 1.22e-08 | 4 | 34 | 3 | CID000333256 | |
| Drug | dermatan sulfate | 3.08e-08 | 220 | 34 | 7 | CID000032756 | |
| Drug | AC1Q6PCP | 4.18e-08 | 230 | 34 | 7 | CID000005267 | |
| Drug | colchine | 7.38e-08 | 383 | 34 | 8 | CID000002833 | |
| Drug | prostacyclin sodium salt | 7.39e-08 | 250 | 34 | 7 | CID000000159 | |
| Drug | hyaluronan | 1.04e-07 | 263 | 34 | 7 | CID000024759 | |
| Drug | chondroitin sulfate | 1.32e-07 | 413 | 34 | 8 | CID000024766 | |
| Drug | silibinin | 1.80e-07 | 285 | 34 | 7 | CID000005213 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 3.47e-07 | 314 | 34 | 7 | CID000447989 | |
| Drug | AC1L1KMJ | 3.88e-07 | 476 | 34 | 8 | CID000030956 | |
| Drug | AC1L18QD | 4.37e-07 | 325 | 34 | 7 | CID000000213 | |
| Drug | losartan | 1.20e-06 | 378 | 34 | 7 | CID000003961 | |
| Drug | 351A | 3.41e-06 | 20 | 34 | 3 | CID000122144 | |
| Drug | Y-27632 | 3.49e-06 | 444 | 34 | 7 | CID000005711 | |
| Drug | 2-amino-4,6-dinitrotoluene | 3.54e-06 | 70 | 34 | 4 | ctd:C035208 | |
| Drug | LMWH | 4.60e-06 | 663 | 34 | 8 | CID000000772 | |
| Drug | AC1L9HPX | 1.06e-05 | 92 | 34 | 4 | CID000445279 | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.07e-05 | 198 | 34 | 5 | 4805_DN | |
| Drug | etodolac | 1.47e-05 | 32 | 34 | 3 | CID000003308 | |
| Drug | isodesmosine | 1.61e-05 | 33 | 34 | 3 | CID000013811 | |
| Drug | aspirin | 1.64e-05 | 563 | 34 | 7 | CID000002244 | |
| Drug | Sirius red | 1.93e-05 | 35 | 34 | 3 | CID005486818 | |
| Drug | AC1MRIIV | 2.68e-05 | 39 | 34 | 3 | CID003518584 | |
| Drug | BPAT-143 | 3.23e-05 | 6 | 34 | 2 | CID000146249 | |
| Drug | In2-7 | 3.23e-05 | 6 | 34 | 2 | CID002816385 | |
| Drug | PD123177 | 3.60e-05 | 43 | 34 | 3 | CID000114899 | |
| Drug | 1zd2 | 4.14e-05 | 45 | 34 | 3 | CID004149241 | |
| Drug | desmosine | 6.77e-05 | 53 | 34 | 3 | CID000025435 | |
| Drug | 1h00 | 7.99e-05 | 56 | 34 | 3 | CID000445950 | |
| Drug | trapidil | 8.42e-05 | 57 | 34 | 3 | CID000005531 | |
| Drug | diphenylamine-2-carboxylate | 1.02e-04 | 164 | 34 | 4 | CID000004386 | |
| Drug | AC1Q641C | 1.08e-04 | 62 | 34 | 3 | CID000005005 | |
| Drug | 4-aminoazobenzene | 1.31e-04 | 66 | 34 | 3 | CID000006051 | |
| Drug | LS-63783 | 1.56e-04 | 804 | 34 | 7 | CID000000231 | |
| Drug | L-3,4-dehydroproline | 1.76e-04 | 73 | 34 | 3 | CID000094284 | |
| Drug | calcium pyrophosphate | 1.83e-04 | 74 | 34 | 3 | CID000024632 | |
| Drug | Span 40 | 1.95e-04 | 14 | 34 | 2 | CID000014927 | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 1.98e-04 | 195 | 34 | 4 | 4124_UP | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 2.02e-04 | 196 | 34 | 4 | 1515_UP | |
| Drug | Flumequine [42835-25-6]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 2276_DN | |
| Drug | Droperidol [548-73-2]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 5690_UP | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 5475_DN | |
| Drug | Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; HL60; HT_HG-U133A | 2.10e-04 | 198 | 34 | 4 | 3004_UP | |
| Drug | Lysergol [602-85-7]; Down 200; 15.8uM; HL60; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 1325_DN | |
| Drug | Dioxybenzone [131-53-3]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 2.14e-04 | 199 | 34 | 4 | 6478_UP | |
| Drug | sodium chloride | 2.44e-04 | 865 | 34 | 7 | CID000000206 | |
| Drug | homocystine | 2.49e-04 | 82 | 34 | 3 | CID000010010 | |
| Drug | phenoxyacetic acid | 3.26e-04 | 18 | 34 | 2 | ctd:C415326 | |
| Drug | sodium dodecyl sulfate | 3.38e-04 | 91 | 34 | 3 | CID000008778 | |
| Drug | ethoxyacetic acid | 4.04e-04 | 20 | 34 | 2 | ctd:C034096 | |
| Drug | gold nanoparticles | 4.56e-04 | 243 | 34 | 4 | CID000023985 | |
| Disease | Stickler syndrome (is_implicated_in) | 5.59e-09 | 4 | 34 | 3 | DOID:0080046 (is_implicated_in) | |
| Disease | Stickler syndrome | 1.40e-08 | 5 | 34 | 3 | cv:C0265253 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.34e-06 | 19 | 34 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | Multiple Epiphyseal Dysplasia | 1.57e-06 | 20 | 34 | 3 | C0026760 | |
| Disease | Cleft Palate | 2.29e-06 | 81 | 34 | 4 | C0008925 | |
| Disease | Stickler syndrome (disorder) | 3.86e-06 | 3 | 34 | 2 | C0265253 | |
| Disease | Stickler syndrome, type 1 | 1.29e-05 | 5 | 34 | 2 | C2020284 | |
| Disease | Multiple Epiphyseal Dysplasia, Dominant | 1.29e-05 | 5 | 34 | 2 | cv:CN043640 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.15e-05 | 53 | 34 | 3 | C4707243 | |
| Disease | Sensory hearing loss | 7.04e-05 | 11 | 34 | 2 | C1691779 | |
| Disease | cleft palate (is_implicated_in) | 8.44e-05 | 12 | 34 | 2 | DOID:674 (is_implicated_in) | |
| Disease | Congenital muscular dystrophy | 8.44e-05 | 12 | 34 | 2 | cv:C0699743 | |
| Disease | Disproportionate short stature | 9.65e-05 | 77 | 34 | 3 | C0878659 | |
| Disease | osteoarthritis (implicated_via_orthology) | 1.34e-04 | 15 | 34 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | Myopia | 1.34e-04 | 15 | 34 | 2 | C0027092 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 1.53e-04 | 16 | 34 | 2 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 1.53e-04 | 16 | 34 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 1.53e-04 | 16 | 34 | 2 | C0025237 | |
| Disease | Spondyloepiphyseal Dysplasia | 1.53e-04 | 16 | 34 | 2 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 1.53e-04 | 16 | 34 | 2 | C3541456 | |
| Disease | Van Buchem disease | 1.73e-04 | 17 | 34 | 2 | C0432272 | |
| Disease | Dyschondroplasias | 2.18e-04 | 19 | 34 | 2 | C0013366 | |
| Disease | Osteochondrodysplasias | 2.18e-04 | 19 | 34 | 2 | C0029422 | |
| Disease | Abortion, Tubal | 2.70e-04 | 109 | 34 | 3 | C0000822 | |
| Disease | Early Pregnancy Loss | 2.70e-04 | 109 | 34 | 3 | C3830362 | |
| Disease | Miscarriage | 2.70e-04 | 109 | 34 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 2.70e-04 | 109 | 34 | 3 | C0000786 | |
| Disease | Sensorineural Hearing Loss (disorder) | 3.21e-04 | 23 | 34 | 2 | C0018784 | |
| Disease | social communication impairment | 6.25e-04 | 32 | 34 | 2 | EFO_0005427 | |
| Disease | Hereditary hearing loss and deafness | 6.35e-04 | 146 | 34 | 3 | cv:C0236038 | |
| Disease | cystatin C measurement | 1.14e-03 | 402 | 34 | 4 | EFO_0004617 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LEYGGQRGDAHGKPG | 31 | Q8N2C9 | |
| KYIGVGKGGALELHG | 141 | Q8WUJ3 | |
| VKGHRGYPGLDGAKG | 286 | P02458 | |
| AHGYLKGTKGPGITG | 456 | P98175 | |
| PDDGKHPDGGLYNKG | 91 | Q9UJU2 | |
| GGGGGGFKHPAFKRR | 156 | Q7L2J0 | |
| GRGLAKHGTQKGGPR | 866 | Q9UPA5 | |
| GQKRAAGGGSYKGHV | 691 | Q92499 | |
| PHYFRSGRGEGPGKK | 1036 | Q9UKJ3 | |
| PNGYGFHLHGEKGKL | 21 | O14745 | |
| GERGQHGPKGEKGYP | 96 | Q9BXJ4 | |
| GGEYKPDKGKGDGRY | 156 | Q8TCZ2 | |
| INGTKGYPGLKGDEG | 536 | P12109 | |
| PGLQGVKGHAGKRGI | 186 | Q14055 | |
| VKGHAGKRGILGDPG | 191 | Q14055 | |
| TGPHGYKGMVGAIGA | 246 | Q14055 | |
| GKRDYNGPKAEGRGG | 191 | O95886 | |
| IYEGIGGPRGEKGQK | 441 | P20908 | |
| AQGEPGLAGYDGHKG | 1301 | Q8IZC6 | |
| GLAGYDGHKGIVGPL | 1306 | Q8IZC6 | |
| TGGRIYGGQKAKPGD | 441 | O00187 | |
| GYPGLPGMRGHKGAK | 421 | P20849 | |
| KKRHGVIGGPNNGGY | 176 | O43781 | |
| GSPGYGSVGRKGAKG | 1651 | A6NMZ7 | |
| KGLKGERGDQGVPGY | 151 | A6NHN0 | |
| GGGKGAIDHYVTPVK | 141 | Q9NX20 | |
| GPKASHGYGGRFGVE | 76 | P14317 | |
| GRSKGGSFHRGAGKP | 51 | A5D8V7 | |
| HGHLRVYEGFGPGKK | 1036 | Q7RTY7 | |
| AFVGRKGGPVFGEKH | 211 | Q8WZA1 | |
| EKGGAYGGGAKLSHN | 901 | Q5JRX3 | |
| RGYIPGKGLGKNEDG | 901 | P63128 | |
| LGAKKEGVGGPADYH | 376 | Q9Y4C5 | |
| PLGGHKGTGYQAGGL | 306 | Q6ZRI6 | |
| EKGDQGKRGPHGLIG | 946 | Q17RW2 | |
| YKGHVGVPGLRGATG | 1226 | Q17RW2 | |
| STDGRGGGDYLKKPG | 266 | Q99943 | |
| GRRGSKGHMNYEGPG | 2266 | Q9H4A3 | |
| LGGKGGPYRLDAGHT | 1581 | A3KMH1 | |
| GGGGERKVGGPHPKY | 446 | Q15223 |